Ignite Creation Date:
2024-05-06 @ 3:37 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02332902
Status:
COMPLETED
Last Update Posted:
2023-12-20
First Post:
2014-12-12
Brief Title:
Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Sponsor:
The University of Texas Health Science Center Houston
Organization:
The University of Texas Health Science Center Houston
Organization Data
Organization:
The University of Texas Health Science Center Houston
Class:
OTHER
Study ID:
HSC-MS-14-0758
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The University of Texas Health Science Center Houston
Lead Sponsor Class:
OTHER
Responsible Party:
Mary Kay Koenig
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The University of Texas Health Science Center Houston
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Texas Neurofibromatosis Foundation | UNKNOWN |